Dew, thanks for the logic behind the TEVA sale. I'll hold my shares for the time being; as I wrote before, I believe the climate for generics in the U.S. especially will be dramatically improving. Too bad much of that may already be priced in!
The future is of course unpredictable, and at best, debatable, therefore all i have left is to see how TEVA has performed in the past in comparison with any company, be it in its sector and/or any other sector over the years.
Market Data 
Markets 
AI
